The key to the AbsolutePRP™ Concentrating System is the ClearVUE Conical Piston. The piston is specially designed to greatly improve the collection of the cell concentrate buffycoat layer. The primary feature of the new ClearVUE Conical Piston is it's the deep conical shape.  The deep conical design perfectly directs the collection of the cell concentrate buffycoat with minimal red cell integration. This provides quality platelet rich plasma and bone marrow concentrate with near perfect collection yields.

The ClearVUE Conical Piston also features enhanced handling of the concentrating device with frictionless motion and a CLEAR VIEW of the buffycoat while its being aspirated, further instilling confidence in the quality of the end product.

With Active Displacement Disc Technology the operator has the flexibility to access the buffycoat concentrate at any point of separation.  The GenesisCS System is not volume dependent or hematocrit dependent. Physicians adore the versatility of GenesisCS and enjoy using a system that can respond to their specific needs.

Prepare 7mL of AbsolutePRP, with high concentrations of regenerative cells, in a SINGLE 5 MINUTE SPIN. This system is designed to accommodate physicians that run a busy practice and mandate superior performance outcomes that is consistent and reliable.

EmCyte Corporation® leads in autologous cellular biologics with products that meet the highest achievable performance standard.  With over 18 years of experience, EmCyte has stayed committed to innovation that truly makes a clinical difference. We have worked to stay on the cutting edge of clinical excellence, making the GenesisCS Component Concentrating System the most advanced concentrating system available.

510(k) Clearance (BK050055)

The GenesisCS Component Concentrating System is designed to be used for the safe and rapid preparation of autologous platelet rich plasma (PRP) from a small sample of blood at the patient's point of care. The PRP can be mixed with autograft and allograft bone prior to application to an orthopedic surgical site as deemed necessary by the clinical use requirements.